Form 4: Regeneron Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Daniel P. Van Plew, EVP & General Manager at Regeneron Pharmaceuticals, sold 969 shares of common stock on December 16, 2024, to cover tax obligations.
Summary
- On December 16, 2024, Daniel P. Van Plew, an Executive Vice President & General Manager at Regeneron Pharmaceuticals, sold 969 shares of common stock.
- The sale was executed at a price of $730.81 per share.
- This transaction was conducted to cover tax obligations.
- Following the transaction, Van Plew directly owns 34,792 shares of Regeneron common stock.
- Van Plew also indirectly owns 1,100 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (stock sale for tax purposes) by an executive, which is neither particularly positive nor negative.
Industry Context
Executive stock sales are a common occurrence, often related to compensation and tax planning. Monitoring these transactions can provide insights into management's perspective on the company's value, although this particular sale appears to be for tax purposes.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant effect given the stated reason (tax obligations).
Key Dates
| Date | Description |
|---|---|
| 12/16/2024 | Date of stock sale transaction |
| 12/18/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.